Last Posted: Aug 27, 2018
- Association of Rapid Molecular Testing With Duration of Respiratory Isolation for Patients With Possible Tuberculosis in a US Hospital
LH Chaisson et al, JAMA Internal Medicine, AUgust 27, 2018 - Molecular Assay Testing to Rule Out Tuberculosis—Be That Early Adopter
M Salfinger, JAMA Internal Medicine, August 27, 2018 - XDR tuberculosis in South Africa: genomic evidence supporting transmission in communities.
Auld Sara C et al. The European respiratory journal 2018 Aug - Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
Kandler Justin L et al. Antimicrobial agents and chemotherapy 2018 Aug - Identifying mixed Mycobacterium tuberculosis infections from whole genome sequence data.
Sobkowiak Benjamin et al. BMC genomics 2018 Aug (1) 613 - A Major Mycobacterium tuberculosis outbreak caused by one specific genotype in a low-incidence country: Exploring gene profile virulence explanations.
Folkvardsen Dorte Bek et al. Scientific reports 2018 Aug (1) 11869 - Epidemiological and genomic determinants of tuberculosis outbreaks in First Nations communities in Canada.
Doroshenko Alexander et al. BMC medicine 2018 Aug (1) 128 - Mixed infections are associated with poor treatment outcomes among newly diagnosed tuberculosis patients independent of pre-treatment heteroresistance.
Shin Sanghyuk S et al. The Journal of infectious diseases 2018 Aug - Advances in the development of molecular genetic tools for Mycobacterium tuberculosis.
Chhotaray Chiranjibi et al. Journal of genetics and genomics = Yi chuan xue bao 2018 Jun - Treating Latent TB infection
CDC Information, August 2018
.png)
No hay comentarios:
Publicar un comentario